← Evidence map

TrialScientific reports2026

Dexmedetomidine for sedation during noninvasive ventilation in COVID-19 patients from the Helmet-COVID randomized clinical trial post-hoc analysis.

Marwa Amer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Dexmedetomidine for sedation during noninvasive ventilation in COVID-19 patients from the Helmet-COVID randomized clinical trial post-hoc analysis. | OpenQuestion